Back to Authors

Jaffee, Elizabeth M.

https://orcid.org/0000-0003-3841-6549

Mayo Clinic

Johns Hopkins University

Citations 3

944 Fibroblasts as paracrine targets of the oncometabolite D-2-HG in the IDH1-mutant cholangiocarcinoma tumor microenvironment
Jain, Prerna , Mody, Kabir , El-Refai, Sherif , Zabransky, Daniel J. , Jaffee, Elizabeth M. , Yarchoan, Mark

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A991-A992

10.1136/jitc-2021-sitc2021.944 Get It

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma
Yarchoan, Mark , Agarwal, Parul , Rao, Shuyun , Dawson, Laura A. , Llovet, Josep M. , Groopman, John D. , El‐Serag, Hashem B. , Monga, Satdarshan P. , Wang, Xin Wei , Roberts, Lewis R. , Gunaratne, Preethi H. , Tsung, Allan , Brown, Kimberly , Lawrence, Theodore S. , Kim, Amy K. , Rabiee, Atoosa , Resar, Linda , Meyer, Jeffrey , He, Aiwu Ruth , Ghoshal, Kalpana , Ryan, Patrick , Jaffee, Elizabeth M. , Guha, Chandan , Mishra, Lopa , Coleman, C. Norman, Ahmed, Mansoor M. , Groopman, John D , El-Serag, Hashem B , Roberts, Lewis R , Wei Wang, Xin , Lawrence, Theodore S , Yarchoan, Mark , Monga, Satdarshan , Villanueva, Augusto , Karasic, Thomas Benjamin , Finn, Richard S. , Karin, Michael , Schwartz, Robert E. , Tanabe, Kenneth K. , Salem, Riad , Singal, Amit G. , Hoshida, Yujin

Cancer Research | September 3, 2019 | Volume: 79 | Issue: 17 | Pages: 4326-4330

10.1158/0008-5472.can-19-0803 Get It

Abstract Hepatocellular carcinoma (HCC) has emerged as a major cause of cancer deaths globally. The landscape of systemic therapy has recently changed, with six additional systemic agents either approved or awaiting approval for advanced stage HCC. While these agents have the potential to improve outcomes, a survival increase of 2–5 months remains poor and falls short of what has been achieved in many other solid tumor types. The roles of genomics, underlying cirrhosis, and optimal use of treatment strategies that include radiation, liver transplantation, and surgery remain unanswered. Here, we discuss new treatment opportunities, controversies, and future directions in managing HCC.
Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer
Simons, J.W., Weber, Christine E., Levitsky, H.J., Nelson, William G. , Lazenby, A, Cohen, Laura K., Finn, C. C., Clift, S , Hauda, Karen M., Leiferman, K M, Owens, Albert H., Piantadosi, Steven , Dranoff, Glenn , Mulligan, Richard C., Pardoll, Drew M. , Marshall, Fray F., Jaffee, Elizabeth M. , Carducci, Michael A. , Beck, Lisa A.

Journal of Urology | January 17, 2006 | Volume: 159 | Issue: 2S | Pages: 617-618

10.1016/s0022-5347(01)63906-5 Get It